Cover Story
FreeWhite House
By Paul Goldberg and Matthew Bin Han Ong
Monica M. Bertagnolli, a professor of surgery at Harvard Medical School, stands poised to become the first woman and the first chair of a clinical trials cooperative group to be named director of the National Cancer Institute.
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research - As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer
- Trump 2016: A look back at the 45th president’s impact on oncology
- What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.” - Menin inhibitors emerge as new treatment for advanced AML
- Kaklamani: The San Antonio Breast Cancer Symposium will focus on deescalating treatment while maintaining outcomes